REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 50 filers reported holding REGULUS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $35,000 | -93.2% | 15,870 | -89.8% | 0.00% | – |
| Q3 2016 | $512,000 | +8.7% | 155,084 | -5.1% | 0.00% | -100.0% |
| Q2 2016 | $471,000 | -52.0% | 163,351 | +15.2% | 0.00% | 0.0% |
| Q1 2016 | $982,000 | -21.4% | 141,773 | -1.1% | 0.00% | 0.0% |
| Q4 2015 | $1,250,000 | +42.2% | 143,371 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $879,000 | -69.1% | 134,545 | -48.2% | 0.00% | -66.7% |
| Q2 2015 | $2,848,000 | -4.1% | 259,739 | +48.2% | 0.00% | 0.0% |
| Q1 2015 | $2,969,000 | +24.9% | 175,320 | +18.3% | 0.00% | +50.0% |
| Q4 2014 | $2,377,000 | +1880.8% | 148,143 | +889.1% | 0.00% | – |
| Q2 2014 | $120,000 | -25.5% | 14,978 | -15.9% | 0.00% | – |
| Q1 2014 | $161,000 | -4.2% | 17,820 | -21.5% | 0.00% | – |
| Q4 2013 | $168,000 | +75.0% | 22,695 | +123.4% | 0.00% | – |
| Q3 2013 | $96,000 | -3.0% | 10,161 | +0.7% | 0.00% | – |
| Q2 2013 | $99,000 | – | 10,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $943,000 | 0.99% |
| DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
| BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
| Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
| Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
| South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |